Acute myelogenous leukemia cells with the MLL-ELL translocation convert morphologically and functionally into adherent myofibroblasts

被引:6
作者
Tashiro, Haruko [1 ]
Mizutani-Noguchi, Mitsuho [1 ]
Shirasaki, Ryosuke [1 ]
Shirafuji, Naoki [1 ]
机构
[1] Teikyo Univ, Sch Med, Dept Hematol Oncol, Itabashi Ku, Tokyo 1738606, Japan
关键词
MLL; ELL; Myofibroblast; CD133; Cancer stem cell; ACUTE MYELOID LEUKEMIAS; GROWTH-FACTOR; STEM-CELLS; GENE; EXPRESSION; CLONING; 11Q23; RNA; T(11-19)(Q23-P13.1); IDENTIFICATION;
D O I
10.1016/j.bbrc.2009.11.104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow-myofibroblasts, a major component of bone marrow-stroma, are reported to originate from hematopoietic stem cells We show in this paper that non-adherent leukemia blasts can change into myofibroblasts When myeloblasts from two cases of acute myelogenous leukemia with a fusion product comprising mixed lineage leukemia and RNA polymerase II elongation factor, were Cultured long term, their morphology changed to that of myofibroblasts with similar molecular characteristics to the parental myeloblasts The original leukemia blasts, when cultured on the leukemia blast-derived myofibroblasts, grew extensively Leukemia blasts can create their own microenvironment for proliferation (C) 2009 Elsevier Inc. All rights reserved
引用
收藏
页码:592 / 597
页数:6
相关论文
共 35 条
[1]  
[Anonymous], 1996, Nat Genet, V14, P86
[2]   CD13/APN is activated by angiogenic signals and is essential for capillary tube formation [J].
Bhagwat, SV ;
Lahdenranta, J ;
Giordano, R ;
Arap, W ;
Pasqualini, R ;
Shapiro, LH .
BLOOD, 2001, 97 (03) :652-659
[3]   ABNORMAL FUNCTION OF THE BONE-MARROW MICROENVIRONMENT IN CHRONIC MYELOGENOUS LEUKEMIA - ROLE OF MALIGNANT STROMAL MACROPHAGES [J].
BHATIA, R ;
MCGLAVE, PB ;
DEWALD, GW ;
BLAZAR, BR ;
VERFAILLIE, CM .
BLOOD, 1995, 85 (12) :3636-3645
[4]   Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFβ1 [J].
Bodo, M ;
Baroni, T ;
Bellucci, C ;
Lilli, C ;
De Ioanni, M ;
Bonifacio, E ;
Moretti, L ;
Becchetti, E ;
Bellocchio, S ;
Delfini, C ;
Lumare, E ;
Tabilio, A .
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 206 (03) :682-692
[5]  
CLARE N, 1982, AM J CLIN PATHOL, V77, P762
[6]  
Götherström C, 2005, HAEMATOLOGICA, V90, P1017
[7]  
Greiling D, 1997, J CELL SCI, V110, P861
[8]   RETRACTED: COX-2 inhibitors suppress integrin α5 expression in human lung carcinoma cells through activation of Erk:: Involvement of Sp1 and AP-1 sites (Retracted article. See vol. 137, pg. 2041, 2015) [J].
Han, S ;
Roman, J .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (04) :536-546
[9]   Functional analysis of the leukemia protein ELL: Evidence for a role in the regulation of cell growth and survival [J].
Johnstone, RW ;
Gerber, M ;
Landewe, T ;
Tollefson, A ;
Wold, WS ;
Shilatifard, A .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1672-1681
[10]   Secretion of interleukin-6 and vascular endothelial growth factor by spindle cell sarcoma complicating Castleman's disease (so-called 'vascular neoplasia') [J].
Kakiuchi, C ;
Ishida, T ;
Sato, H ;
Katano, H ;
Ishiko, T ;
Mukai, H ;
Kogi, M ;
Kasuga, N ;
Takeuchi, K ;
Yamane, K ;
Fukayama, M ;
Mori, S .
JOURNAL OF PATHOLOGY, 2002, 197 (02) :264-271